Technology areas: Biotechnology & Pharmaceuticals • Networking & Security • Medical Devices & Mechanical Engineering
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Institució Catalana de Recerca i Estudis Avançats manages 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 6 distinct examiners and 5 distinct art units, indicating a broad but somewhat concentrated technical scope. The use of 5 distinct art units suggests that the institution's research covers several different biotechnological or pharmaceutical classifications. This distribution requires the institution to navigate the requirements of 5 distinct art units, each with its own set of examination standards and timelines.
DEO, DUY VU NGUYEN is the busiest examiner for the portfolio, currently overseeing 1 pending office action. With 6 pending office actions in total and 6 distinct examiners involved, the workload is spread evenly, with no single examiner handling multiple cases. This lack of examiner concentration means that prosecution strategies must be tailored to the specific tendencies of six different individuals. The presence of 6 distinct examiners across 5 distinct art units highlights the need for a versatile approach to the institution's diverse Biotechnology & Pharmaceuticals portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §103 only | 1 (12%) |
| §102 only | 1 (12%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEO, DUY VU NGUYEN | 1 | 82.5% | +7.3% |
| STAVROU, CONSTANTINA E | 1 | 42.4% | +35.6% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +39.1% |
| GELAGAY, SHEWAYE | 1 | 71.9% | +45.4% |
| KIM, YOUNG J | 1 | 64.8% | +18.2% |
| LOUIS, LATOYA M | 1 | 52.3% | +40.3% |
| ABEDIN, SHANTO | 1 | 87.3% | +23.1% |
| WESTFALL, SARAH ANN | 1 | 5.0% | +25.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18574352 | METHOD FOR MANUFACTURING AN EMITTER FOR ELECTROSPRAY GENERATORS | DEO, DUY VU NGUYEN | 63d |
| 18259058 | A NETWORK NODE, A TRANSMITTER AND A RECEIVER FOR QUANTUM KEY DISTRIBUTION OVER AN OPTICAL FIBER NETWORK | ABEDIN, SHANTO | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261205 | A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM | LOUIS, LATOYA M | 16d overdue |
| 18562448 | SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS | STAVROU, CONSTANTINA E | — |
| 18556456 | COMPOUNDS FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 18376681 | Optical System for Phase Modulation | GELAGAY, SHEWAYE | — |
| 18547904 | MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY | KIM, YOUNG J | — |
| 18037191 | MEASURING AND IMPROVING ATTENTION | WESTFALL, SARAH ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261205 | A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM | LOUIS, LATOYA M | 16d overdue |
| 18562448 | SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS | STAVROU, CONSTANTINA E | — |
| 18556456 | COMPOUNDS FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 18376681 | Optical System for Phase Modulation | GELAGAY, SHEWAYE | — |
| 18547904 | MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY | KIM, YOUNG J | — |
| 18259058 | A NETWORK NODE, A TRANSMITTER AND A RECEIVER FOR QUANTUM KEY DISTRIBUTION OVER AN OPTICAL FIBER NETWORK | ABEDIN, SHANTO | — |
| 18037191 | MEASURING AND IMPROVING ATTENTION | WESTFALL, SARAH ANN | — |
| Art Unit | Apps |
|---|---|
| 1713 | 1 |
| 1632 | 1 |
| 1622 | 1 |
| 2400 | 1 |
| 1681 | 1 |
| 3785 | 1 |
| 2494 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18574352 | METHOD FOR MANUFACTURING AN EMITTER FOR ELECTROSPRAY GENERATORS | DEO, DUY VU NGUYEN | 1713 | §103 | Final Rejection | 63d | Pending | Dec 27, 2023 |
| 18562448 | SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS | STAVROU, CONSTANTINA E | 1632 | §102§103§112 | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18556456 | COMPOUNDS FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §102§112 | Final Rejection | — | Pending | Oct 20, 2023 |
| 18376681 | Optical System for Phase Modulation | GELAGAY, SHEWAYE | 2400 | §102§112 | Final Rejection | — | Pending | Oct 04, 2023 |
| 18547904 | MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY | KIM, YOUNG J | 1681 | §101§112 | Final Rejection | — | Pending | Aug 25, 2023 |
| 18261205 | A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM | LOUIS, LATOYA M | 3785 | §102§103§112 | Final Rejection | 16d overdue | Pending | Jul 12, 2023 |
| 18259058 | A NETWORK NODE, A TRANSMITTER AND A RECEIVER FOR QUANTUM KEY DISTRIBUTION OVER AN OPTICAL FIBER NETWORK | ABEDIN, SHANTO | 2494 | §102 | Final Rejection | — | Pending | Jun 22, 2023 |
| 18037191 | MEASURING AND IMPROVING ATTENTION | WESTFALL, SARAH ANN | 3791 | §101§102§112 | Final Rejection | — | Pending | May 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitució Catalana de Recerca i Estudis Avançats has 8 pending office actions as of October 2026, spread across 8 art units and 8 examiners.
Duy Vu Nguyen Deo has the most, with 1 of Institució Catalana de Recerca i Estudis Avançats's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
